🖊️ Marksans Pharma – Pullback Near Channel Support

🔶 1. Channel Support Retested After a strong rally and sharp fall, the stock has now retraced toward the lower end of its rising parallel channel. The green trendline, acting as dynamic support, has previously halted corrections twice—making it a critical level to monitor. 🔶 2. Previous Resistance Zone Retested as Support (~₹215–220) This zone coincides with historical resistance and recent consolidation before the last up-leg. Price finding stability here would indicate buying interest around past breakout zones. 🔶 3. No Fresh Breakdown Yet Despite selling pressure, no confirmed breakdown of channel support has occurred. Structure still valid unless price closes below ₹215 on high volume, which would shift bias toward ₹191–170 support cluster. 🧠 Technical View “It’s sitting near crucial support. A reversal pattern here with volume confirmation could offer swing opportunity. Below ₹215, caution advised.” This is watchlist-worthy, not blind buy zone yet. Price action > prediction. 📢 Disclaimer: This is for informational purposes only. Nothing herein constitutes a buy or sell recommendation. I may or may not be holding a position in the stock mentioned. 🧑‍💼 Rajneesh Sharma is a SEBI-registered Research Analyst (Reg. No. INH000020332). 📄 Investments are subject to market risks. Read all related documents carefully before investing.